Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.3689
+0.0127 (3.57%)
At close: Jan 22, 2026, 4:00 PM EST
0.3659
-0.0030 (-0.81%)
After-hours: Jan 22, 2026, 5:16 PM EST
Silo Pharma Employees
Silo Pharma had 3 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$24,034
Profits / Employee
-$1,692,263
Market Cap
4.91M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 1 | 50.00% |
| Dec 31, 2021 | 2 | 1 | 100.00% |
| Dec 31, 2020 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BiomX | 57 |
| GeoVax Labs | 17 |
| VivoSim Labs | 13 |
| Revelation Biosciences | 9 |
| Indaptus Therapeutics | 7 |
| Galmed Pharmaceuticals | 6 |
| CNS Pharmaceuticals | 5 |
| Matinas BioPharma Holdings | 3 |
SILO News
- 23 days ago - Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15 - GlobeNewsWire
- 2 months ago - Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD - GlobeNewsWire
- 3 months ago - Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain - GlobeNewsWire
- 3 months ago - Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program - GlobeNewsWire
- 3 months ago - Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company's Commitment to Multi-Chain Growth - GlobeNewsWire
- 3 months ago - Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci) - GlobeNewsWire
- 4 months ago - Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 4 months ago - Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire